Ondine Biomedical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.2%.

Top 13 shareholders own 53.06% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
39.5%	Carolyn Cross	109,469,879	US$9.8m	0%	no data
4.96%	Janus Henderson Group plc	13,760,445	US$1.2m	0%	no data
3.35%	Lansdowne Partners Limited	9,298,090	US$832.8k	0%	0.02%
2.87%	Chelverton Asset Management Limited	7,957,311	US$712.7k	0%	0.05%
1.03%	Nicolas Loebel	2,852,088	US$255.5k	0%	no data
0.41%	Aegon Asset Management UK Plc	1,129,231	US$101.1k	0%	no data
0.37%	Premier Fund Managers Ltd.	1,035,284	US$92.7k	0%	no data
0.17%	Simon Sinclair	472,927	US$42.4k	0%	no data
0.13%	Jean Charest	353,356	US$31.6k	0%	no data
0.11%	Junaid Bajwa	317,735	US$28.5k	0%	no data
0.075%	Jean Duvall	207,934	US$18.6k	0%	no data
0.062%	Craig Tooman	173,278	US$15.5k	0%	no data
0.031%	Michael Farrar	86,642	US$7.8k	0%	no data